Stephen E Sherman
Overview
Explore the profile of Stephen E Sherman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen A, Khan S, Margulies C, Viswanathan R, Lele S, Blaha L, et al.
Nat Biotechnol
. 2023 May;
42(3):458-469.
PMID: 37127662
Inefficient knock-in of transgene cargos limits the potential of cell-based medicines. In this study, we used a CRISPR nuclease that targets a site within an exon of an essential gene...
2.
Cooper T, Sherman S, Bell G, Dayarathna T, McRae D, Ma J, et al.
Stem Cells Dev
. 2021 Jan;
30(5):247-264.
PMID: 33403929
The secretome of mesenchymal stromal cells (MSCs) is enriched for biotherapeutic effectors contained within and independent of extracellular vesicles (EVs) that may support tissue regeneration as an injectable agent. We...
3.
Sherman S, Agudo J
Methods Mol Biol
. 2020 Jul;
2171:25-39.
PMID: 32705633
Functional studies of specific stem cell populations often require depletion of tissue-specific stem cells in an in vivo model to allow for the interrogation of their contribution to the maintenance...
4.
Sherman S, Kuljanin M, Cooper T, Lajoie G, Hess D
Stem Cells Dev
. 2020 Apr;
29(14):895-910.
PMID: 32336222
Fluorescent-activated cell sorting (FACS) remains a powerful tool to enrich blood-derived progenitor cells for the establishment of highly proliferative endothelial colony-forming cells (ECFC). Further investigation remains necessary to determine whether...
5.
Cooper T, Sherman S, Bell G, Ma J, Kuljanin M, Jose S, et al.
Stem Cells
. 2020 Jan;
38(5):666-682.
PMID: 31904137
Multipotent/mesenchymal stromal cells (MSCs) exist within a variety of postnatal tissues; however, global proteomic analyses comparing tissue-specific MSC are limited. Using human bone marrow (BM)-derived MSCs as a gold standard,...
6.
Procyshyn R, Lamoure J, Katzman M, Skinner P, Sherman S
J Pharm Pharm Sci
. 2019 Nov;
22(1):548-566.
PMID: 31730504
Paliperidone palmitate is a second generation antipsychotic, approved for the treatment of schizophrenia in the form of the long-acting injectable (LAI) products INVEGA SUSTENNA® (once monthly injection) and INVEGA TRINZA®...
7.
Dhillon J, Young S, Sherman S, Bell G, Amsden B, Hess D, et al.
J Biomed Mater Res A
. 2018 Nov;
107(3):571-585.
PMID: 30390406
Cell-based therapies involving the injection of adipose-derived stem/stromal cells (ASCs) within rationally designed biomaterials are a promising approach for stimulating angiogenesis. With this focus, the current work explored the effects...
8.
Sherman S, Bell G, Teoh H, Al-Omran M, Connelly K, Bhatt D, et al.
JACC Basic Transl Sci
. 2018 Aug;
3(2):327-329.
PMID: 30062217
No abstract available.
9.
Cooper T, Sherman S, Kuljanin M, Bell G, Lajoie G, Hess D
Stem Cells
. 2018 Jan;
36(5):723-736.
PMID: 29377410
Blood-derived progenitor cell transplantation holds potential for the treatment of severe vascular diseases. Human umbilical cord blood (UCB)-derived hematopoietic progenitor cells purified using high aldehyde dehydrogenase (ALDH ) activity demonstrate...
10.
Young S, Sherman S, Cooper T, Brown C, Anjum F, Hess D, et al.
Biomaterials
. 2018 Jan;
159:146-160.
PMID: 29324306
A promising strategy for treating peripheral ischemia involves the delivery of stem cells to promote angiogenesis through paracrine signaling. Treatment success depends on cell localization, retention, and survival within the...